Publications by authors named "Matthew Milowsky"

Claim this Profile
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Matthew Milowsky

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.
Michael S Sturdivant, Andrew S Truong, Mi Zhou, Elliott D Toomer, Wolfgang Beckabir, Matthew I Milowsky

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.
Cindy Y Jiang, Hyunsoo Hwang, Ilana Y Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder, Matthew I Milowsky

Oncologist· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.
Amanda Nizam, Charles B Nguyen, Jinju Li, Emily C Zabor, Pavlos Msaouel, Matthew I Milowsky

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of renal mass biopsy on decision-making experience for clinical T1 renal masses.
Kathryn H Gessner, Allison M Deal, Amir Feinberg, Shannon Myers, Katherine Poulos, Matthew I Milowsky

J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.
Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, Dingwei Ye, Mads Agerbaek, Matthew Milowsky

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.
Tanya Jindal, Cindy Y Jiang, Omar Alhalabi, Charles B Nguyen, Eugene Oh, Matthew I Milowsky

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement.
Zachary S Feuer, Richard S Matulewicz, Ramsankar Basak, Donna A Culton, Kimberly Weaver, Matthew Milowsky

Tumori· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.
Antoine G van der Heijden, Harman Max Bruins, Albert Carrion, Richard Cathomas, Eva Compérat, Matthew I Milowsky

Eur Urol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium.
Catherine C Fahey, Sean Clark-Garvey, Sima Porten, Ashish M Kamat, Thomas W Flaig, Matthew I Milowsky

Curr Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data.
Tanya Jindal, Cindy Jiang, Omar Alhalabi, Amanda Nizam, Charles Nguyen, Matthew I Milowsky

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, Leslie Ballas, Rick Bangs, Matthew I Milowsky

Bladder Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology.
Sandy Figiel, Anthony Bates, David A Braun, Renu Eapen, Markus Eckstein, Matthew I Milowsky

Eur Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
Matthew D Galsky, Johannes Alfred Witjes, Jürgen E Gschwend, Matthew I Milowsky, Michael Schenker

J Clin Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201).
Jeffrey L Jensen, Olivia Bobek, Irenaeus C C Chan, Brian C Miller, David W Hillman, Matthew I Milowsky

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Curing More Patients with Bladder Cancer - A New Perioperative Strategy.
Matthew I Milowsky

N Engl J Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instruments.
Hannah Kay, Tracy L Rose, Matthew I Milowsky, Angela B Smith, Marc A Bjurlin

Int J Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.
N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, Jay A Moore, Zoe Fleischmann, Matthew I Milowsky

Cancer Res Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Rapidly Progressive De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer.
Aryan Dalal, Sean Clark-Garvey, Andrew Gdowski, Sophia Zhang, Sara E Wobker, Matthew I Milowsky

Case Rep Oncol Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective Study.
Amir Feinberg, Kathryn H Gessner, Allison M Deal, Hillary M Heiling, Shannon Myers, Matthew I Milowsky

J Urol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.
Tämer El Saadany, Anja Lorch, Matthew I Milowsky, Ursula Maria Vogl, Richard Cathomas

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Matthew I Milowsky

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory myofibroblastic tumor in a patient with X-Linked hypophosphatemia: A case of Occam's razor or Hickam's dictum?
Farhan Chowdry, Kelsey M Miller, Ersan Altun, Sara E Wobker, Gary S Gottesman, Matthew I Milowsky

Urol Case Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer.
Blaine Brower, Asia McCoy, Hiba Ahmad, Cheryl Eitman, I Alex Bowman, Matthew I Milowsky

Front Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.
David J McConkey, Brian C Baumann, Stephanie Cooper Greenberg, David J DeGraff, Scott E Delacroix, Matthew I Milowsky

Bladder Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis